Norbert Bender has been made the new chief medical officer of the synthetic biology company Evolva Holding SA. Dr. Bender is an M.D. from the University of Frankfurt, from where he also has a PhD in Biochemistry and Pharmacy. He has twenty years of experience in the pharmaceutical industry and was involved in the successful development of the ACE inhibitor Ramipril. He has been a medical consultant for Evolva since October 2010.
Copyright 2011 Evernow Publishing Ltd